INCITE (2019–2023) focused specifically on innovative chemoenzymatic integrated processes for commodity and fine chemical production.
BICT SRL
Italian biotech SME specializing in chemoenzymatic process design and downstream processing for fine and commodity chemical production.
Their core work
BICT SRL is an Italian biotechnology and chemistry SME specializing in enzymatic and chemical process development for the production of high-value compounds. Their work sits at the intersection of biocatalysis and industrial chemistry — designing integrated processes that convert biological or chemical feedstocks into commodity and fine chemicals. In the INCITE project, they contributed to chemoenzymatic synthesis routes and downstream processing solutions, indicating hands-on capability in process design and scale-up. Their earlier work in TASCMAR suggests a background in natural product discovery from marine sources, giving them a broader toolbox that spans bioprospecting through to chemical processing.
What they specialise in
INCITE keywords explicitly include integrated downstream processing, suggesting capability in separation, purification, and recovery steps within bioprocess workflows.
TASCMAR (2015–2019) addressed cultivation of marine invertebrates and access to original bioactive compounds, pointing to earlier expertise in marine biotechnology.
INCITE targeted both commodity chemicals (bulk production focus) and fine chemicals (high-value, precise synthesis), indicating versatility across market segments.
How they've shifted over time
BICT's H2020 trajectory shows a clear pivot from marine biotechnology toward industrial green chemistry. Their first project (TASCMAR, 2015–2019) was rooted in natural product discovery — cultivating marine invertebrates to access bioactive compounds — with no specific process chemistry keywords. By 2019, with INCITE, the focus had shifted decisively toward chemoenzymatic synthesis and integrated downstream processing for chemical manufacturing. This suggests BICT moved from upstream bioprospecting toward process engineering and scale-up, building industrial applicability on top of an earlier natural-products foundation.
BICT is moving toward industrial bioprocess integration — partners seeking green chemistry or enzymatic routes to fine and commodity chemicals are likely a strong fit for future collaboration.
How they like to work
BICT participates exclusively as a consortium partner — they have never led a project — which positions them as a specialist contributor rather than a project driver. With 20 unique partners across 9 countries in only two projects, they appear comfortable working in medium-to-large international consortia. This suggests they bring a specific technical capability that other consortium members depend on, rather than acting as a generalist integrator.
BICT has built a network of 20 consortium partners across 9 countries over just two projects, suggesting they are embedded in active, broad European research networks despite their small size. Their Italian base with wide European reach indicates they operate comfortably in multi-national project environments.
What sets them apart
BICT is a rare Italian SME that bridges marine natural product research and industrial chemoenzymatic process chemistry — a combination that is uncommon and commercially relevant as industries seek greener synthesis routes. Their ability to operate across both discovery (TASCMAR) and process scale-up (INCITE) phases makes them a versatile partner for consortia that need both scientific credibility and practical process development. For businesses or researchers targeting enzymatic production of fine chemicals or green chemical manufacturing, BICT brings applied SME agility alongside EU-validated research experience.
Highlights from their portfolio
- INCITELargest project by funding (€981,050) and the clearest signal of BICT's technical identity — chemoenzymatic integrated processes for commodity and fine chemical production with direct industrial relevance.
- TASCMAREarliest H2020 engagement, placing BICT in the Blue Growth sector and demonstrating a bioprospecting background in marine-derived bioactive compounds that underpins their current biocatalysis work.